Public Profile
Julia Rotow, MD

- Assistant Professor of Medicine
- Dana-Farber Cancer Institute
- Boston, MA
Program Name | Last Air Date | Hosts/Guests |
---|---|---|
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings | 04/22/2025 |
Program Name | Last Air Date | Hosts/Guests |
---|---|---|
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings | 04/22/2025 |